Rite Aid proposed closing nearly a fourth of its 2,100 pharmacies and declaring bankruptcy, people familiar with the matter told The Wall Street Journal in a Sept. 22 story. 

A Chicago hospital strengthened its product disposal rules in 2021 after its pharmacy director at the time sold empty COVID-19 vaccine vials on Craigslist, CBS News reported Sept. 20. 

Philadelphia-based Penn Medicine has appointed Nishaminy Kasbekar, PharmD, as vice president and chief pharmacy officer, according to a Sept. 21 LinkedIn post. 

Baptist Health South Florida is partnering with EveryDose, a digital health company, to digitize medication adherence processes. 

An FDA panel voted 19-0 Sept. 21 to reject ITCA 650, an experimental Type 2 diabetes drug delivery product, after refusing approval twice. 

Kaiser Permanente pharmacy workers in Oregon and Washington plan to strike for three weeks in October, adding to the growing tally of what could be the largest healthcare strike in U.S. history. 

Before the FDA possibly approves the nation's first needle-free EpiPen product, the agency wants a San Diego-based drugmaker to conduct another study. 

Baptist Health, a nine-hospital system based in Louisville, Ky., is constructing a $40 million central fill pharmacy in La Grange, Ky. Here are five things to know about the project:

As we move closer to the end of this year, it is unfortunate to note that U.S. drug shortages are at an all-time high. Also unfortunate is that this is not a new issue. Drug shortages have been occurring in the United States for far too long.   

ADHD-related medication errors rose 299 percent between 2000 and 2021, according to new research published in Pediatrics on Sept. 18.

Numerous Humira biosimilars are on the market after AbbVie's 20-year exclusive on the rheumatoid arthritis biologic, but they aren't fostering much competition, KFF Health News reported Sept. 19. 

The FDA reduced its therapeutic equivalence rating in Accord Healthcare's tacrolimus oral capsules because of safety concerns, but the generic's approval remains, the agency said Sept. 19. 

Tom Vadaketh, executive vice president and CFO of pharmaceutical company Bausch Health Cos., has resigned from his role and will be leaving the company effective Oct. 13.

Over the last few years, “doing more with less” has become a mantra for most hospitals and health systems. Many are now looking at specialty pharmacy services as a way to strengthen their financial portfolios, reduce administrative burden and deliver more patient-centered care.

Besides filling the chief pharmacy officer and pharmacy director roles, pharmacists are filling other C-suite and senior leadership jobs in hospitals. 

The shortages of Novo Nordisk's Ozempic and Wegovy, a Type 2 diabetes and weight loss drug, respectively, could continue for years, Forbes reported Sept. 16. 

Since late August, six medications have fallen into short supply, including one cancer therapy.

The potential is growing for MDMA-assisted therapy, also known as ecstasy, to be approved for treating PTSD as more research finds success. 

Following an FDA advisory committee's determination that a common ingredient in over-the-counter cough and cold medicines is ineffective, the agency released a statement  clarifying it has not yet made a final decision on the matter. 

The Federal Trade Commission is targeting brand-name drugmakers that are improperly listing patents, which can weaken competition.